1. Abenova M, Shaltynov A, Jamedinova U, Semenova Y. Worldwide child
routine vaccination hesitancy rate among parents of children aged 0–6 years:
a systematic review and meta-analysis of cross-sectional studies. Vaccines.
2023;12(1): 31.
2. Tate J, Aguado T, Belie JD, Holt D, Karafillakis E, Larson HJ, et al. The life-course
approach to vaccination: harnessing the benefits of vaccination throughout
life. Vaccine. 2019;37(44):6581–3.
3. Doherty M, Buchy P, Standaert B, Giaquinto C, Prado-Cohrs D. Vaccine impact:
benefits for human health. Vaccine. 2016;34(52):6707–14.
4. Vanderslott S, Dattani S, Spooner F., Roser M. Vaccination. OurWorldInData.
org; 2015. Available from: https://ourworldindata.org/vaccination.
5. Tomljenovic H, Bubic A, Erceg N. It just doesn’t feel right - the relevance of
emotions and intuition for parental vaccine conspiracy beliefs and vaccination uptake. Psychol Health. 2020;35(5):538–54.
6. Suppli CH, Hansen ND, Rasmussen M, Valentiner-Branth P, Krause TG, Mølbak
K. Decline in HPV-vaccination uptake in Denmark - the association between
HPV-related media coverage and HPV-vaccination. BMC Public Health.
2018;18(1):1360.
7. Wise J. Child vaccination rates drop in England as MMR uptake falls for fourth
year. BMJ (Online). 2018;362: k3967.
8. Ather F, Sherin A. Vaccine hesitancy: A threat to vaccine preventable disease
programs. Khyber Med Univ J. 2019;11(2):65–6. https://doi.org/10.35845/kmu
j.2019.19538.
9. McGregor S, Goldman RD. Determinants of parental vaccine hesitancy. Can
Fam Physician. 2021;67(5):339–41.
10. Haroune V, King L. Factors contributing to parental ‘vaccine hesitancy’ for
childhood immunisations. Nurs Child Young People. 2020;32(4):20–5.
11. Giambi C, Fabiani M, D’Ancona F, Ferrara L, Fiacchini D, Gallo T, et al.
Parental vaccine hesitancy in Italy– Results from a National survey. Vaccine.
2018;36(6):779–87.
12. Deal A, Halliday R, Crawshaw AF, Hayward SE, Burnard A, Rustage K, et al.
Migration and outbreaks of vaccine-preventable disease in europe: a systematic review. Lancet Infect Dis. 2021;21(12):e387–98.
13. Habersaat KB, Pistol A, Stanescu A, Hewitt C, Grbic M, Butu C, et al. Measles
outbreak in Romania: understanding factors related to suboptimal vaccination uptake. Eur J Public Health. 2020;30(5):986–92.
14. Henszel L, Kanitz EE, Grisold A, Holzmann H, Aberle SW, Schmid D. Vaccination status and attitude among measles cluster cases in Austria, 2019. Int J
Environ Res Public Health. 2020;17(24): 9377.
15. Woudenberg T, van Binnendijk RS, Sanders EAM, Wallinga J, de Melker HE,
Ruijs WLM, et al. Large measles epidemic in the Netherlands, May 2013 to
March 2014: changing epidemiology. Euro Surveill. 2017;22(3):11–9.
16. Mchale P, Keenan A, Ghebrehewet S. Reasons for measles cases not being
vaccinated with MMR: investigation into parents’ and carers’ views following a
large measles outbreak. Epidemiol Infect. 2016;144(4):870–5.
17. Toure A, Saadatian-Elahi M, Floret D, Lina B, Casalegno J, Vanhems P. Knowledge and risk perception of measles and factors associated with vaccination decisions in subjects consulting university affiliated public hospitals in
lyon, france, after measles infection. Hum Vaccines Immunotherapeutics.
2014;10(6):1755–61.
18. Knol M, Urbanus A, Swart E, Mollema L, Ruijs WL, Binnendijk, RSV et al. Large
ongoing measles outbreak in a religious community in the Netherlands since
May 2013. Euro Surveill. 2013;18(36):pii=20580.
19. López Hernández B, Laguna Sorinas J, Marín Rodríguez I, Gallardo García V,
Pérez Morilla E, Mayoral Cortés JM. Spotlight on measles 2010: An ongoing
outbreak of measles in an unvaccinated population in Granada, Spain, October to November 2010. Euro Surveill. 2010;15(50):19746.
20. World Health Organization EpiBrief. A report on the epidemiology of selected
vaccine-preventable diseases in the European Region. https://www.who.in
t/europe/publications/i/item/WHO-EURO-2023-7691-47458-69761. 2023.
Accessed 10 Jan 2024.
21. World Health Organization EpiData. A monthly summary of the epidemiological data on selected vaccine-preventable diseases in the WHO European
Region. https://www.who.int/europe/publications/m/item/epidata-7-2023.
2023. Accessed 7 Jan 2024.
22. Burki T. Measles in Europe. Lancet Infect Dis. 2018;18(10):1070–1.
23. Robert A, Funk S, Kucharski AJ. The measles crisis in Europe—the need for a
joined-up approach. Lancet (British edition). 2019;393(10185):2033.
24. Muscat M, Gebrie B, Efstratiou A, Datta SS, Daniels D. Diphtheria in the WHO
European Region, 2010 to 2019. Euro surveillance: bulletin européen sur les
maladies transmissibles. 2022;27(8):1.
25. Dekkers OM, Vandenbroucke JP, Cevallos M, Renehan AG, Altman DG, Egger
M. COSMOS-E: guidance on conducting systematic reviews and meta-analyses of observational studies of etiology. PLoS Med. 2019;16(2):e1002742.
26. Rasmussen I, Wallace S, Mengshoel AT, Høiby EA, Brandtzæg P.
Diphtheria outbreak in Norway: lessons learned. Scand J Infect Dis.
2011;43(11–12):986–9.
27. Homola L, Klučka J, Helešic J, Jirsenská Z, Kratochvíl M, Dominik P, et al.
Unvaccinated child tetanus from nasal toy battery. Cent Eur J Public Health.
2021;29(4):322–4.
28. European Centre for Disease Prevention and Control. Vaccination schedules
for individual European countries and specific age groups. https://www.ec
dc.europa.eu/en/immunisation-vaccines/EU-vaccination-schedules. 2013.
Accessed 5 Dec 2023.
29. Lam T, Ranjan R, Newark K, Surana S, Bhangu N, Lazenbury A, et al. A recent
surge of fulminant and early onset subacute sclerosing panencephalitis
(SSPE) in the united kingdom: an emergence in a time of measles. Eur J
Pediatr Neurol. 2021;34:43–9.
30. Ferren M, Horvat B, Mathieu C. Measles encephalitis: towards new therapeutics. Viruses. 2019. https://doi.org/10.3390/v11111017.
31. Holt E. 41 000 measles cases in Europe since the beginning of 2018. Lancet
(British edition). 2018;392(10149):724.
32. Karafillakis E, Larson HJ, ADVANCE consortium. The benefit of the doubt or
doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations. Vaccine. 2017;35(37):4840–50.
33. Alsubaie SS, Gosadi IM, Alsaadi BM, Albacker NB, Bawazir MA, Bin-Daud N, et
al. Vaccine hesitancy among Saudi parents and its determinants. Result from
the WHO SAGE working group on vaccine hesitancy survey tool. Saudi Med J.
2019;40(12):1242–50.
34. Ruijs WLM, Hautvast JLA, Ijzendoorn G, WJCv A, Kvd V, Hulscher MEJL. How
orthodox Protestant parents decide on the vaccination of their children: a
qualitative study. BMC Public Health. 2012;12(1):408.
35. Fournet N, Mollema L, Ruijs WL, Harmsen IA, Keck F, Durand JY, et al. Undervaccinated groups in Europe and their beliefs, attitudes and reasons for
non-vaccination; two systematic reviews. BMC Public Health. 2018;18(1):196.
36. Harmsen IA, Ruiter RAC, Paulussen TGW, Mollema L, Kok G, de Melker HE.
Factors that influence vaccination decision-making by parents who visit an
anthroposophical child welfare center: a focus group study. Adv Prev Med.
2012;2012:175694–7.
37. Rose L, Browne M, Bryden G. Scepticism towards vaccination is associated with anti-scientific attitudes and related cultural factors. Focus Altern
Complement Ther. 2016;21(1):58–9.
38. Duffell E. Attitudes of parents towards measles and immunisation after a
measles outbreak in an anthroposophical community. J Epidemiol Community Health (1979). 2001;55(9):685–6.
39. HANRATTY B, HOLT T, PATTERSON DUFFELLE, RAMSAY W, WHITE M. UK
measles outbreak in non-immune anthroposophic communities: the
implications for the elimination of measles from Europe. Epidemiol Infect.
2000;125(2):377–83.
40. Suijkerbuijk AW, Woudenberg T, Hahne SJ, Lochlainn LN, Melker HEd,
Ruijs WLM, et al. Economic costs of measles outbreak in the netherlands,
2013–2014. Emerg Infect Dis. 2015;21(11):2067–9.
41. Moser CA, Reiss D, Schwartz RL. Funding the costs of disease outbreaks
caused by non-vaccination. J Law Med Ethics. 2015;43(3):633–47.
42. Bruns R, Hosangadi D, Trotochaud M, Kirk Sell T. COVID‑19 vaccine misinformation and disinformation costs an estimated $50 to $300 million each day.
Baltimore (MD): Johns Hopkins Center for Health Security; 2021.
43. Al-Tammemi AB, Tarhini Z. Beyond equity: advocating theory-based health
promotion in parallel with COVID-19 mass vaccination campaigns. Public
Health Pract (Oxford England). 2021;2:100142.
44. Leask J, Kinnersley P, Jackson C, Cheater F, Bedford H, Rowles G. Communicating with parents about vaccination: a framework for health professionals.
BMC Pediatr. 2012;12(1):154.
45. Attwell K, Smith DT, Ward PR. The unhealthy other’: how vaccine rejecting
parents construct the vaccinating mainstream. Vaccine. 2018;36(12):1621–6.
46. Cohen DA, Scribner RA, Farley TA. A structural model of health behavior: a
pragmatic approach to explain and influence health behaviors at the population level. Prev Med. 2000;30(2):146–54.
47. Goldenberg MJ. Vaccine hesitancy: Public trust, expertise, and the war on
science. Pittsburgh (PA): University of Pittsburgh Press; 2021.
48. Bardosh K, de Figueiredo A, Gur-Arie R, Jamrozik E, Doidge J, Lemmens T, et al.
The unintended consequences of COVID-19 vaccine policy: why mandates,
passports and restrictions May cause more harm than good. BMJ Global
Health. 2022;7(5):e008684.
49. World Health Organization. Immunization Agenda 2030. https://cdn.who.int/
media/docs/defaultsource/immunization/strategy/ia2030/ia2030draft4wha_
b88503791fce4847bfd15d2c9d9e32f8.pdf?sfvrsn=5389656e_66&download=
true. 2020. Accessed 30 Jan 2024.
50. Albrecht D. Vaccination, politics and COVID-19 impacts. BMC Public Health.
2022;22(1):96